Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Bcl-2 Family (Bcl-2, Mcl-1, Bim and Bax) and Btk Expression in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Lymphocytes in Different Lymphoid Compartments and Changes during Btk Inhibitor Therapies (ibrutinib or acalabrutinib)

Ozren Jaksic, Marija Ivic, Branimir Gizdic, Zdravko Mitrovic, Ena Soric, Ozana Jaksic, Anamarija Vrkljan Vuk, Mario Pirsic, Vlatko Pejsa, Branimir Jaksic, Rajko Kusec

Blood (2022) 140 (Supplement 1): 7002–7003.

https://doi.org/10.1182/blood-2022-169649

Published: 2022

Journal Articles

Prognostic Value of TTM with TTM Distribution and Ball Score in Relapsed/Refractory Ibrutinib Treated B-CLL - in the Real-World Setting

Ozren Jaksic, MDPhD, Marija Ivic, MD, Rajko Kusec, MD PhD, Zdravko Mitrovic, MD PhD, Mario Pirsic, MD, Branimir Jaksic, MD PhD, David Cicic, MD, Vlatko Pejsa, MD PhD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-143030

Published: 2020

Journal Articles

Different Pattern of Expression of CD52, CD20 and CXCR-4 in Peripheral Blood, Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia (B-CLL),

Ozren Jaksic, MD, PhD, Branimir Gizdic, Tajana Stoos Veic, MD, Vlatka Pandzic Jaksic, MD, PhD, Rajko Kusec, MD, PhD, Vlatko Pejsa, MD, PhD, Branimir Jaksic, MD, PhD

Blood (2011) 118 (21): 3877.

https://doi.org/10.1182/blood.V118.21.3877.3877

Published: 2011

Journal Articles

Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Ozren Jaksic, MD, PhD, Branimir Gizdic, Tajana Stoos Veic, MD, Vlatka Pandzic Jaksic, MD, PhD, Rajko Kusec, MD, PhD, Vlatko Pejsa, MD, PhD, Branimir Jaksic, MD, PhD

Blood (2010) 116 (21): 3607.

https://doi.org/10.1182/blood.V116.21.3607.3607

Published: 2010

Journal Articles

Post-Thaw Viability of Cryopreserved Hematopoietic Progenitor Cell Grafts Influences Patients' Predisposition towards Infectious Complications in the Post-Transplant Period.

Radovan Vrhovac, Zinaida Peric, Silvana Jurenec, Ika Kardum-Skelin, Biljana Jelic-Puskaric, Zoran Siftar, Jasna Mesaric, Hrvoje Minigo, Branimir Jaksic

Blood (2009) 114 (22): 4666.

https://doi.org/10.1182/blood.V114.22.4666.4666

Published: 2009

Journal Articles

Febrile Neutropenia Following Autologous Stem Cell Transplantation in Patients with Lymphoma

Radovan Vrhovac, Zinaida Peric, Matko Kalac, Alen Ostojic, Visnja Kovacevic, Suzana Bukovski-Simonoski, Arjana Tambic-Andrasevic, Hrvoje Minigo, Branimir Jaksic

Blood (2008) 112 (11): 4379.

https://doi.org/10.1182/blood.V112.11.4379.4379

Published: 2008

Journal Articles

Alemtuzumab (CAMPATH®, MABCAMPATH®) Has Superior Progression Free Survival (PFS) vs Chlorambucil as Front-Line Therapy for Patients with Progressive B-Cell Chronic Lymphocytic Leukemia (BCLL).

Peter Hillmen, Aleksander Skotnicki, Tadeusz Robak, Branimir Jaksic, Cynthia Sirard, Jiri Mayer

Blood (2006) 108 (11): 301.

https://doi.org/10.1182/blood.V108.11.301.301

Published: 2006

Journal Articles

More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML)

Rajko Kusec, Ozren Jaksic, Slobodanka Ostojic, Ika Kardum-Skelin, Radovan Vrhovac, Branimir Jaksic

Blood (2006) 108 (1): 405–406.

https://doi.org/10.1182/blood-2005-12-5128

Published: 2006

Journal Articles

Differences between Peripheral Blood, Lymph Nodes and Bone Marrow in Expression of Integrins, ICAMs, CD38 and CD31 Correlate with Clinical Characteristics in B-CLL.

Branimir Jaksic, MD, PhD, Ozren Jaksic, MD, MSc, Mirjana M. Kardum-Paro, MSc, Ika Kardum-Skelin, MD, MSc

Blood (2005) 106 (11): 4981.

https://doi.org/10.1182/blood.V106.11.4981.4981

Published: 2005

Journal Articles

Dexamethasone Versus Methyl-Prednisolone in Induction Therapy for Adult Acute Lymphoblastic (ALL) and Non-Hodgkin Lymphoma (NHL) Patients ≤ 60 Yrs Old: Final Results of the Eortc All-4 Phase III Trial.

Boris Labar, MD, PhD, Stefan Suciu, PhD, Petra Muus, MD, Roelof Willemze, MD, PhD, Jean-Pierre Marie, MD, Georges Fillet, MD, Zwi Berneman, MD, Branimir Jaksic, MDPhD, Walter Feremans, MD, Dominique Bron, MD, Henry Sinnige, MD, Martin Mistrik, MD, G. Vreugdenhil, MD, Robrecht De Bock, MD, Damir Nemet, MD, Caroline Gilotay, Theo de Witte, MDPhD, Sergio Amadori, MD

Blood (2005) 106 (11): 1834.

https://doi.org/10.1182/blood.V106.11.1834.1834

Published: 2005

Journal Articles

Preliminary Safety and Efficacy Report of a Randomized Trial of Alemtuzumab vs Chlorambucil as Front-Line Therapy in 297 Patients with Progressive B-Cell Chronic Lymphocytic Leukemia.

Peter Hillmen, MB ChB, PhD, Aleksander B. Skotnicki, MD, PhD, Tadeusz Robak, MD, PhD, Jiri Mayer, MD, PhD, Branimir Jaksic, MD, PhD, Vojo Vukovic, MD, PhD, Steven Weitman, MD, PhD

Blood (2004) 104 (11): 2505.

https://doi.org/10.1182/blood.V104.11.2505.2505

Published: 2004

Journal Articles

CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow

Ozren Jaksic, Mirjana Mariana Kardum Paro, Ika Kardum Skelin, Rajko Kusec, Vlatko Pejsa, Branimir Jaksic

Blood (2004) 103 (5): 1968–1969.

https://doi.org/10.1182/blood-2003-11-3890

Published: 2004

NARROW

Bcl-2 Family (Bcl-2, Mcl-1, Bim and Bax) and Btk Expression in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Lymphocytes in Different Lymphoid Compartments and Changes during Btk Inhibitor Therapies (ibrutinib or acalabrutinib)

Prognostic Value of TTM with TTM Distribution and Ball Score in Relapsed/Refractory Ibrutinib Treated B-CLL - in the Real-World Setting

Different Pattern of Expression of CD52, CD20 and CXCR-4 in Peripheral Blood, Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia (B-CLL),

Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Post-Thaw Viability of Cryopreserved Hematopoietic Progenitor Cell Grafts Influences Patients' Predisposition towards Infectious Complications in the Post-Transplant Period.

Febrile Neutropenia Following Autologous Stem Cell Transplantation in Patients with Lymphoma

Alemtuzumab (CAMPATH®, MABCAMPATH®) Has Superior Progression Free Survival (PFS) vs Chlorambucil as Front-Line Therapy for Patients with Progressive B-Cell Chronic Lymphocytic Leukemia (BCLL).

More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML)

Differences between Peripheral Blood, Lymph Nodes and Bone Marrow in Expression of Integrins, ICAMs, CD38 and CD31 Correlate with Clinical Characteristics in B-CLL.

Dexamethasone Versus Methyl-Prednisolone in Induction Therapy for Adult Acute Lymphoblastic (ALL) and Non-Hodgkin Lymphoma (NHL) Patients ≤ 60 Yrs Old: Final Results of the Eortc All-4 Phase III Trial.

Preliminary Safety and Efficacy Report of a Randomized Trial of Alemtuzumab vs Chlorambucil as Front-Line Therapy in 297 Patients with Progressive B-Cell Chronic Lymphocytic Leukemia.

CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only